Should I Buy CWK? CWK 2026 Analysis

Should You Buy Cushman & Wakefield Ltd (CWK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

16.160

1 Day change

6.88%

52 Week Range

17.400

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: Price ($15.33) is sitting right on first support (S1 $15.382) and looks oversold (RSI-6 ~26), which favors a short-term rebound despite weak momentum.
Upside levels to watch: first reclaim $16.25 pivot, then $17.11 (R1); those align with the recent bullish analyst targets ($18–$19).
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock today.
No notable hedge-fund/insider trend signals and no recent politician/congress trades—decision is mainly technical + fundamental/analyst driven into earnings.

Technical Analysis

Trend/Momentum: MACD histogram is negative (-0.168) and expanding lower → downtrend pressure still present.
Oversold condition: RSI-6 around 26 suggests the stock is stretched to the downside and more prone to a bounce.
Moving averages: Converging MAs → market is compressing; next break above pivot could accelerate a recovery move.
Key levels: Current $15.33 is slightly below S1 $15.382; next support S2 $14.849. Overhead resistance at $16.245 pivot, then $17.109 (R1).
Pattern-based projection (provided): Similar-pattern analysis indicates a 70% probability skewed to gains over 1D/1W/1M, supporting a near-term rebound thesis.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Open-interest put/call ratio 0.44 implies more calls than puts outstanding (bullish tilt).
Activity: Very light tape (today volume = 1 contract), so sentiment signal is mostly from OI rather than fresh flows.
Volatility: 30D IV 51.84 vs HV 36.87 → options are pricing elevated movement; IV percentile 63.75 suggests volatility is relatively high vs recent history.
Near-term catalyst timing: Earnings on 2026-02-19 (pre-market) can keep IV supported and drive directional moves.

Technical Summary

Sell

Buy

Positive Catalysts

- Fundamental trajectory: Latest quarter showed strong YoY growth in revenue, EPS, and net income.

Neutral/Negative Catalysts

- Technical pressure still bearish: MACD is negative and worsening, meaning the stock can stay weak even if oversold.
- Margin headwind: Gross margin declined YoY in the latest reported quarter, which can cap multiple expansion if it persists.
- CRE sensitivity: Business performance is tied to commercial real-estate transaction/leasing cycles; any slowdown can quickly hit brokerage/services activity.
- Thin options volume: Limited real-time options flow makes it harder to confirm a strong, fresh bullish push today.

Financial Performance

Latest reported quarter: 2025/Q3
Revenue: $2.606B, +11.16% YoY (healthy top-line recovery).
Net income: $51.4M, +52.52% YoY (profit improving faster than sales).
EPS: $0.22, +57.14% YoY (strong earnings momentum).
Profitability: Gross margin 16.43%, down ~4.53% YoY (key item to monitor—growth is good, but margin compression is a blemish).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Trend: Net-positive shift with upgrades and raised targets from late 2025 into early 2026.
Key actions: Citi upgraded to Buy (PT $18) and highlighted improving transaction/leasing plus deleveraging as catalysts; Morgan Stanley reiterated Overweight and raised PT to $19; Barclays initiated Equal Weight with PT $18.
Wall Street pros: Expectation of gradual CRE recovery, potential outsized earnings growth, and balance-sheet deleveraging supporting multiple expansion.
Wall Street cons: Some firms still frame the space as a measured recovery (not a straight-line rebound), implying sensitivity to macro/CRE conditions and execution risk.

5 Analyst Rating

Wall Street analysts forecast CWK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CWK is 17.88 USD with a low forecast of 16.5 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 15.120

Low

16.5

Averages

17.88

High

Current: 15.120

Low

16.5

Averages

17.88

High

Morgan Stanley

Overweight

maintain

$19

AI Analysis

2026-01-16

Reason

Morgan Stanley

Price Target

$19

AI Analysis

2026-01-16

maintain

Overweight

Reason

Morgan Stanley raised the firm's price target on Cushman & Wakefield to $19 from $16.50 and keeps an Overweight rating on the shares. The firm maintained an in-Line view of the REIT space with a +15% expected total return. Apartments, billboards, and data centers added to most preferred sectors, and industrial, cold storage and triple net moved to neutral, the analyst tells investors in a research note.

Barclays

Equal Weight

initiated

$18

2025-12-02

Reason

Barclays

Price Target

$18

2025-12-02

initiated

Equal Weight

Reason

Barclays initiated coverage of Cushman & Wakefield with an Equal Weight rating and $18 price target. The firm expects the commercial real estate market will continue its gradual recovery. CBRE and Newmark Group are best positioned to outperform, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CWK

Unlock Now

CWK Should I Buy

CWK Should I Buy

Should You Buy Cushman & Wakefield Ltd (CWK) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch